Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 364710, 13 pages
http://dx.doi.org/10.1155/2015/364710
Research Article

Decreased Regulatory T Cells in Vulnerable Atherosclerotic Lesions: Imbalance between Pro- and Anti-Inflammatory Cells in Atherosclerosis

1Department of Internal Medicine I, Friedrich-Schiller-University, 07747 Jena, Germany
2Institute of Forensic Medicine, Friedrich-Schiller-University, 07743 Jena, Germany
3Department of Vascular Surgery, Friedrich-Schiller-University, 07747 Jena, Germany
4Department of Vascular Surgery, Thüringen Klinik Saalfeld, 07318 Saalfeld, Germany

Received 27 July 2014; Accepted 20 October 2014

Academic Editor: Dianne Cooper

Copyright © 2015 Ilonka Rohm et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Weber and H. Noels, “Atherosclerosis: current pathogenesis and therapeutic options,” Nature Medicine, vol. 17, no. 11, pp. 1410–1422, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Niessner, K. Sato, E. L. Chaikof, I. Colmegna, J. J. Goronzy, and C. M. Weyand, “Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-α,” Circulation, vol. 114, no. 23, pp. 2482–2489, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. W. Han, K. Shimada, W. Ma-Krupa et al., “Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation,” Circulation Research, vol. 102, no. 5, pp. 546–553, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. Hawiger, K. Inaba, Y. Dorsett et al., “Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo,” The Journal of Experimental Medicine, vol. 194, no. 6, pp. 769–779, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer, “Inducing and expanding regulatory T cell populations by foreign antigen,” Nature Immunology, vol. 6, no. 12, pp. 1219–1227, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Mor, D. Planer, G. Luboshits et al., “Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 893–900, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. Klingenberg, N. Gerdes, R. M. Badeau et al., “Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1323–1334, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. K. Robertson, M. Rudling, X. Zhou, L. Gorelik, R. A. Flavell, and G. K. Hansson, “Disruption of TGF-β signaling in T cells accelerates atherosclerosis,” Journal of Clinical Investigation, vol. 112, no. 9, pp. 1342–1350, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. F. Toole, “ACAS recommendations for carotid endarterectomy,” The Lancet, vol. 347, no. 8994, article 121, 1996. View at Google Scholar · View at Scopus
  10. H. J. M. Barnett, D. W. Taylor, M. Eliasziw et al., “Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis,” The New England Journal of Medicine, vol. 339, no. 20, pp. 1415–1425, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, “Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II),” Journal of Vascular Surgery, vol. 33, supplement 1, pp. S1–S75, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. H. C. Stary, A. B. Chandler, R. E. Dinsmore et al., “A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 9, pp. 1512–1531, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Yilmaz, M. Lochno, F. Traeg et al., “Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques,” Atherosclerosis, vol. 176, no. 1, pp. 101–110, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I,” Circulation, vol. 108, no. 14, pp. 1664–1672, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. Virmani, F. D. Kolodgie, A. P. Burke et al., “Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2054–2061, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. R. M. Steinman and M. C. Nussenzweig, “Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 351–358, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. Profumo, B. Buttari, M. E. Tosti et al., “Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization,” Journal of Cardiovascular Surgery, vol. 54, no. 3, pp. 349–357, 2013. View at Google Scholar · View at Scopus
  19. Y. V. Bobryshev and R. S. Lord, “Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques,” Journal of Histochemistry & Cytochemistry, vol. 53, no. 6, pp. 781–785, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. B. Lutz and G. Schuler, “Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?” Trends in Immunology, vol. 23, no. 9, pp. 445–449, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. R. M. Steinman, D. Hawiger, K. Liu et al., “Dendritic cell function in Vivo during the steady state: a role in peripheral tolerance,” Annals of the New York Academy of Sciences, vol. 987, pp. 15–25, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Penna, M. Vulcano, S. Sozzani, and L. Adorini, “Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells,” Human Immunology, vol. 63, no. 12, pp. 1164–1171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Pichyangkul, T. P. Endy, S. Kalayanarooj et al., “A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity,” The Journal of Immunology, vol. 171, no. 10, pp. 5571–5578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Legein, L. Temmerman, E. A. L. Biessen, and E. Lutgens, “Inflammation and immune system interactions in atherosclerosis,” Cellular and Molecular Life Sciences, vol. 70, no. 20, pp. 3847–3869, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. Y. V. Bobryshev and R. S. A. Lord, “S-100 positive cells in human arterial intima and in atherosclerotic lesions,” Cardiovascular Research, vol. 29, no. 5, pp. 689–696, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Yadav, C. Louvet, D. Davini et al., “Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo,” The Journal of Experimental Medicine, vol. 209, no. 10, pp. 1713–1722, 2012. View at Google Scholar
  27. O. J. de Boer, J. J. van der Meer, P. Teeling, C. M. van der Loos, and A. C. van der Wal, “Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions,” PLoS ONE, vol. 2, no. 8, article e779, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. Patel, S. H. Chung, G. White, S. Bao, and D. S. Celermajer, “The “atheroprotective” mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques,” International Journal of Cardiology, vol. 145, no. 2, pp. 183–187, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. B. Dietel, I. Cicha, C. J. Voskens, E. Verhoeven, S. Achenbach, and C. D. Garlichs, “Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells,” Atherosclerosis, vol. 230, no. 1, pp. 92–99, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. C. Weber, A. Schober, and A. Zernecke, “Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 1997–2008, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. George, “Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis,” Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 9, pp. 531–540, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. W. Peeters, W. E. Hellings, D. P. V. De Kleijn et al., “Carotid atherosclerotic plaques stabilize after stroke insights into the natural process of atherosclerotic plaque stabilization,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 1, pp. 128–133, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. Crisby, G. Nordin-Fredriksson, P. K. Shah, J. Yano, J. Zhu, and J. Nilsson, “Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization,” Circulation, vol. 103, no. 7, pp. 926–933, 2001. View at Publisher · View at Google Scholar · View at Scopus